| Application no. and date | 15798956.7 (espacenet) (Federated) (European Patent Register), 20150528 | | Patent/reg. no. and date | DK/EP 3155017, 20240110 | | Publication date | 20170419 | | Priority no. and date | US 201462004156 P, 20140528 | | EP pub. no. and date |
EP 3155017 20170419 | | Effective date | | | Applicant/owner | Mederis Diabetes, LLC, 7515 Guinevere Drive
Sugar Land, Texas 77479, US | | Applicant ref. no. | 1706304 | | Inventor | NESTOR, John, J., 725 Lynwood Drive
Encinitas, CA 92024, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 47/50 (2017.01) , A61P 31/10 (2006.01) , C07K 14/605 (2006.01) , C07K 19/00 (2006.01) | | Title | Forbedrede lægemidler til insulinresistens | | Int. application no. | US2015033042 | | Int. publication no. | WO2015184177 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
